Highlights:

• FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol
• This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial
• Next steps include obtaining single IRB approval, site initiations and clinical start-up activities ahead of commencement of patient...